5UBM
Crystal structure of human C1s in complex with inhibitor gigastasin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-07-23 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9537 |
Spacegroup name | P 31 2 1 |
Unit cell lengths | 89.350, 89.350, 146.871 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 41.372 - 2.500 |
R-factor | 0.179 |
Rwork | 0.177 |
R-free | 0.22230 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1elv |
RMSD bond length | 0.004 |
RMSD bond angle | 0.872 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 53.300 | 2.640 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.150 | |
Number of reflections | 24136 | |
<I/σ(I)> | 10.8 | 2.1 |
Completeness [%] | 100.0 | 100 |
Redundancy | 8.7 | 8.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.5 | 277 | 0.1 M Bis-Tris, pH 5.5, 25 % PEG 3350 |